Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Risk for emergently treated hypocalcemia with denosumab increases with worsening CKD
28 Nov 2024
Individuals with worsening chronic kidney disease (CKD) are at greater risk for emergently treated hypocalcemia with denosumab, and the highest risk is observed among dialysis-dependent (DD) patients and those with CKD–mineral and bone disorder (CKD-MBD), reveals a study.








